Volunteer Profile

Dr. Praveen Vikas, MD

The University of Iowa

Contact Details

The University of Iowa

Volunteer Bio  




Current Employment:




Clinical Assistant Professor




The University of Iowa, Holden Comprehensive Cancer Center, Iowa city, IA




Breast Medical Oncology.


Melanoma and General Oncology

 Medical Director




McCreery Cancer center, Fairfield, IA, 2 days/week, (Outreach), General Hem/Oncology




Recent Employments:




Dec. 2017 -Present:




The University of Iowa College of Medicine, Iowa city, IA.




 July 2015-Dec. 2017




University of Iowa Community Medical services (UICMS) d/b/a University of Iowa Health Care (UIHC), Iowa City, IA and The University of Iowa college of Medicine




 June 2011- July 2015




University of Iowa Community Medical Services d/b/a University of Iowa Health Care, Iowa City, IA.




Faculty Appointments:




December 2017- Present




Clinical Assistant Professor, University of Iowa




 




July 2015 to December 2017




Clinical Visiting Assistant Professor, University of Iowa




July 2012-June 2015




Adjunct Clinical Assistant Professor, University of Iowa




 




June 2009 to May 2011




Clinical Instructor, East Tennessee State University, TN.




Administrative / Leadership




July 2011 to May 2015




Cancer Liaison Physician (CLP), Commission on Cancer




Cancer Committee, McCreery Cancer Center, Ottumwa Regional




1001 Pennsylvania Avenue, Ottumwa, Iowa-52501




January 2014- July 2015




Cancer Conference Chair, Cancer Committee




 June 2011 to July 2015




Hospice Medical Director and Board Member.




Hospice Serving Davis and Wapello counties




927 E. Pennsylvania Avenue, Ottumwa, Iowa-52501




July 2012- June 2014




President




Wapello County Medical Society of Iowa.




 




June 2011- Present




Medical Director




McCreery Cancer Center, Ottumwa/Fairfield, Iowa.




Scientific Committee Memberships:




July 2018- Present




Nominated Member, American Society of Clinical Oncology (ASCO) Practice Guidelines Implementation Network




June 2019- Present




Nominated Member, ASCO Multi-Site Guideline Advisory Group




 June 2019- Present




Nominated Member, Consensus Panel, ASCO Management of Hereditary Breast Cancer Guideline




 November 2018- June 2019




ASCO Guideline Expert Panel Member: “Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision-Making for Early-Stage, Operable Breast Cancer.” 




February 2019- Present




Scientific Reviewer




Protocol Review and Monitoring Committee (PRMC)




Holden Comprehensive Cancer Center, Iowa city.




Clinical Research:




June 2011- Present




Senior Primary Investigator / Board Member




NCI- NCORP Iowa-Wide Oncology Research Coalition




IRB JCHC McCreery Cancer center, Fairfield/Ottumwa, IA. 




July 2015 - Present




Primary and Sub-Investigator, Holden Comprehensive Cancer Center




University of Iowa Hospitals and Clinics, Iowa City, IA.




 




Volunteer Scientific Activity:




SITC (Society for Immunotherapy of Cancer) Meeting Coverage Correspondent - 2019 ASCO (American Society for Clinical Oncology) Annual Meeting (5/31/19-6/4/19)




 




Past Clinical Experience:




September 2008 to May 2009




Attending Hospitalist, Internal Medicine




Wellmont Physician Services




Holston Valley Medical Center, Kingsport, TN







Education and Training




06/01/2009 to 05/31/2011




Fellowship, Medical Oncology




Department of Hematology/Oncology




East Tennessee State University 




Johnson City, TN-37604




04/01/2011 to 04/30/2011 (Elective)




Bone Marrow Transplant Elective




Vanderbilt University and VA medical center




Nashville, TN




07/01/2008 to 08/31/2008




Chief Residency




Department of Internal Medicine.




East Tennessee State University.




07/01/2005 to 06/30/2008




 Residency, Internal Medicine




Department of Internal Medicine




East Tennessee State University




 10/01/2006 to 10/31/2006 (Elective)




Hematology Elective




Vanderbilt University Medical Center




Nashville, TN




 08/2004 to 06/2005




Student, Public Health




Saint Xavier University, Chicago, IL




 Medical Education




12/1996 to 10/2002.




M.B., B.S (M.D.)




Smt. N.H.L. Municipal Medical College




Gujarat University, Ahmedabad, India.




Board Certificate/Licensure:







    •  ABIM Board Certified in Internal Medicine, 2008, Recertified 2018









    • ABIM Board Certified in Medical Oncology, 2011







    • ECFMG Certified, 2004







    • License, State of Iowa, Active, 39452







    • License, State of Tennessee, Retired, 43850






 




Professional Memberships




 







    • American Society of Clinical Oncology







    • American Society of Hematology







    • American college of Physicians.







    • Society for Immunotherapy of Cancer






Grant/ Research Projects




 







    • Co-Investigator           






National Palliative Care Research Center Grant.




            July 2016 –Present (Ongoing)




PI: Stephanie Gilbertson-White




Use of telehealth technologies for symptom management support for people with advanced cancer living in rural communities




University of Iowa and McCreery cancer center.




 







    • Co-Investigator






University of Iowa College of Nursing Dean's Research Award and Iowa




Cancer Consortium grant.




August 2015- Present (Ongoing)




PI: Stephanie Gilbertson-White




Stress Management Intervention Development for Patients with Advanced cancer: A qualitative Study.




University of Iowa Holden Comprehensive Cancer center and McCreery Cancer center




 







    • Co-Investigator






Cancer Epidemiology and Population Sciences Oberley grant




Holden Comprehensive Cancer Center




June 2019- Present




PI: Mary Charlton




The role of rurality, treatment networks, and national accreditation in providing quality cancer care: a mixed-methods study of Iowa and Kentucky hospitals:




 







    • Project Chair- Comprehensive Cancer Control Concept Grant






Iowa Cancer Consortium / Iowa Department of Public Health




Dec. 1, 2013-June 1, 2014.




            Obesity, Physical Inactivity and Cancer: Let’s raise the awareness.




 







    • Project Collaborator-Comprehensive Cancer Control Concept Grant






Iowa Cancer Consortium. Project chair: Stephanie Gilbertson-White, PhD.




November 2015- June 2016




Acceptability of using Telehealth Technologies as part of Cancer Symptom Management Program in a Community Cancer Clinic.




 




 




 




 




Submitted Grant, Awaiting Decision:




 




Oncology Associated Symptoms & Individualized Strategies (OASIS): A technology-enabled, patient-centered, symptom management intervention for rural residents. R-01 Submitted, Role: Co-Investigator.




 




Manuscript in progress:




 







    • Therapeutic potential of combining PARP inhibitor and immunotherapy in solid tumors. Praveen Vikas, Nicholas Borcherding, Adithya Chennamadhabani, Rohan Garje






 







    • Treatment of Stage IV Colon Cancer in the United States: A Patterns of Care Analysis :Xiang Gao, Amanda R. Kahl, Paolo Goffredo, Praveen Vikas, Imran Hassan, Mary E. Charlton






 




Peer reviewed Publications:




 







    • t (15; 17) associated with Primary Myelofibrosis: A case report of an unusual clinical presentation and diagnostic dilemma






Nadiminti K, Silverman M, Bhagavathi S, Vikas P




OncoTargets and Therapy. 11 July 2019 Volume 2019:12 Pages 5449—5455




 




 









Henry NL, Somerfield MR, Abramson VG, Ismaila N, Allison KH, Anders CK, Chingos DT, Eisen A, Ferrari BL, Openshaw TH, Spears PA, Vikas P, Stearns V.




J Clin Oncol. 2019 Jun 17:JCO1900948. doi: 10.1200/JCO.19.00948. [Epub ahead of print] PMID:31206315




 







    • The clinical promise of immunotherapy in triple-negative breast cancer.






Vikas P, Borcherding N, Zhang W.




Cancer Manag Res. 2018;10:6823-6833. Published 2018 Dec 10. doi:10.2147/CMAR.S185176. Review.  PMID :30573992




 







    • Keeping tumors in check: A mechanistic review of clinical response and resistance to immune checkpoint blockade in cancer






Borcherding N, Kolb R, Gullicksrud J, Vikas P, Zhu Y, Zhang W.




J Mol Biol. 2018 Jul 6;430(14):2014-2029. doi: 10.1016/j.jmb.2018.05.030. Epub 2018 May 22. Review. PMID: 29800567




 







    • Engaging Stakeholders in the Development of an eHealth Intervention for Cancer Symptom Management for Rural Residents






Gilbertson-White S, Yeung CW, Saeidzadeh S, Tykol H, Vikas P, Cannon A.




J Rural Health. 2018 Apr 25. doi: 10.1111/jrh.12297.




PMID: 29696696




 







    • Palliative and supportive interventions to improve patient-reported outcomes in rural residents with cancer






Stephanie Gilbertson-White, Seyedehtanaz Saeidzadeh,Chi W Yeung, Hannah Tykol and Praveen Vikas




The Journal of Community and Supportive Oncology. Review.




JCSO 2017;15(5):e248-e255




 







    • Challenges of Rural Cancer Care in the United States.






Charlton M, Schlichting J, Chioreso C, Ward M, Vikas P.




Oncology (Williston Park). 2015 Sep;29(9). pii: 213346. Review.




PMID: 26384798




 







    • Allogeneic stem cell transplantation and targeted therapy for FLT3-ITD positive acute myeloid leukemia: an update.






Hu B, Vikas P, Mohty M, Savani BN.




Expert Rev Hematol. 2014 Apr;7(2):301-15. doi: 10.1586/17474086.2014.857596. Epub 2013 Dec 6. Review.




PMID: 24308526




 







    • Plerixafor in AL amyloidosis: improved graft composition and faster lymphocyte      recovery after auto-SCT in patient with end-stage renal-disease.






Dunn D, Vikas P, Jagasia M, Savani BN.




Bone Marrow Transplant. 2012 Aug;47(8):1136-7. doi: 10.1038/bmt.2011.226. Epub 2011 Nov 14. Review. 




PMID: 22080973




 







    • Primary mediastinal Yolk Sac Tumor: A Rarely Encountered Neoplasm  









    1. Moukharskaya, P. Vikas, F. Swan Jr., K. Krishnan, T. Roy, Ryland P.Byrd, Jr.






Journal of the Kentucky Medical Association, August 2010/Vol. 108




 




 




National/International Meeting Abstracts:




 







    • Oncology Associated Symptoms and Individualized strategies (OASIS): Precision symptoms management for rural patients with advanced cancer. ASCO Annual meeting, June 2019.






Praveen Vikas, Stephanie Gilbertson-White, Tannaz Saeidzadeh, Yelena Perkhounkova; J Clin Oncol 37, 2019 (suppl; abstr e23155)




 







    • Single Autologous Stem Cell Transplant (ASCT) Followed By Two Years of Post-Transplant Therapy in Recently Diagnosed Elderly Multiple Myeloma (MM) Patients. Safety and Response Results from the Prospective Phase II Trial (NCT01849783). ASH Meeting 2018






Nadiminti, K., Strouse, C., Vikas, P., Dozeman, L., Schultz, A., Berns, G., Claus, J., Mott, S. L., Farooq, U., Silverman, M., Tomasson, M., Zhan, F., & Jethava, Y. (2018). Blood, 132(Suppl 1), 2153. https://doi.org/10.1182/blood-2018-99-118443.




 







    • Early Intensive Therapy in Multiple Myeloma Using Tandem Transplantation with Novel Conditioning and Two Years Maintenance: A Single Institution Experience.  ASH Meeting 2018






Nadiminti, K., Strouse, C., Vikas, P., Dozeman, L., Schultz, A., Mott, S. L., Claus, J., Farooq, U., Silverman, M., Tomasson, M., Zhan, F., Jethava, Y., & Tricot, G. J. (2018) .Blood, 132(Suppl 1), 2152.https://doi.org/10.1182/blood-2018-99-113890




 







    • Unusual Cytoplasmic Crystalline Inclusions in a Patient with Acute Myeloid Leukemia with Myelodysplasia-Related Changes: A Rare Finding






Sadaf Ilyas, Praveen Vikas, Koyamangalath Krishnan, John C. King, Talat Parveen. College of American Pathologists Annual Meeting (CAP '11). Archives of Pathology & Laboratory Medicine: September 2011, Vol. 135, No. 9, pp. 1102-1230




 




 







    • A RARE LUNG CANCER-WITH GOOD OUTCOME.









    1. Vikas, M Al Shathir, K Chakraborty, M Rogers, A Hamati and M Al-Abbadi. Journal of Investigative Medicine: February 2011 - Volume 59 - Issue 2






Poster presentation at Southern Regional Meeting, New Orleans, Louisiana,




            Abstract 213. (February 17-19, 2011)




 







    • Could Buerger disease be burned out?






P.Vikas, H.Ismail,




SOUTHERN ABSTRACTS: Case Reports in Cardiovascular Medicine, February 8, 2007.Abstract, Journal of Investigative Medicine. 55(1):S251, January 1, 2007




2007 Southern Regional meeting at New Orleans, LA.




Awards:







    • Case Report Award for oral presentation at 2007 Southern Regional meeting at






New Orleans, LA.




Editorial Board:




 







    • Integrative Clinical and Practical Hematology







    • Journal of Oncology and Radiology.






 




Invited Peer Reviews Meeting Abstracts/Journals







    • Year 2019: SITC (Society for Immunotherapy of Cancer) 34th Annual meeting Abstract reviewer






Journal for ImmunoTherapy of Cancer, Clinical Epidemiology, Drug Design, Development and Therapy, Cancer Management and Research, OncoTargets and Thearpy, Molecular Biology reports, Pathology and Clinical research







    • Year 2018: Cancer Management and Research, OncoTargets and Therapy, Breast cancer: Targets and Therapy.







    • Year 2017 :  Breast cancer: Targets and Therapy,  International Journal of women's Health







    • Year 2016 : Breast cancer: Targets and Therapy, OncoTargets and Therapy, Cancer Management and Research







    • Year 2015 : International Journal of Women's Health , Dove Medical Press Ltd






 




Invited Grand Rounds:







    • PARP Inhibitors: Advancing Personalized Medicine for Patients with Metastatic Breast Cancer. Genesis Medical Center, Davenport, IA 2/20/19.







    • Breast cancer, An overview, East Tennessee State University, TN. 7/6/2010